CDC Independent Immunization Panel Meets on Johnson & Johnson Vaccine
The U.S. Centers for Disease Control (CDC) Immunization Committee is meeting Friday to consider lifting a pause on use of the Johnson & Johnson COVID-19 vaccine. The pause was widely implemented last week following the discovery of six U.S. cases of a rare and severe type of blood clots in people who had received the shot. On April 13, the CDC, in a joint statement with the U.S. Food and Drug Administration, recommended a pause on use of the vaccine, “out of an abundance of caution” and to give experts an opportunity to examine the blood clot cases and see if any additional cases were found. CDC officials have said since that “a handful” of other cases were being investigated, but offered no details, except to say…